Trial Profile
Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jan 2014
Price :
$35
*
At a glance
- Drugs K 312 (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions
- Sponsors Kowa Research Institute
- 08 Jan 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 05 Oct 2013 New trial record